Search
Doravirine
Doravirine is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) intended to be administered in combination with other antiretroviral medicines. Doravirine is available by itself or as a combination product of doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg). Doraviri...
Doravirine Action Pathway
smpdb.ca/view/SMP0125908Drug actionDoravirine is available by itself or as a combination product of doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg). … Doravirine is taken orally and transported into the cell via a drug transporter. Doravirine then inhibits reverse transcriptase which inhibits HIV-1 replication.
Drugs: DoravirineIslatravir
go.drugbank.com/drugs/DB15653ApprovedInvestigational[A275492] On April 21, 2026, the FDA approved the first fixed-dose combination containing islatravir (0.25 mg) and the NNRTI doravirine (100 mg), marketed as IDVYNSO, as a complete once-daily regimen for
Human Immunodeficiency Virus Type 1 (HIV-1)
go.drugbank.com/conditions/DBCOND0042885Tenofovir disoproxil
go.drugbank.com/drugs/DB00300ApprovedInvestigationalTenofovir disoproxil fumarate (a prodrug of tenofovir), marketed by Gilead Sciences under the trade name Viread, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (nRTIs). This drug ...
Categories: lamivudine, tenofovir disoproxil and doravirineHuman Immunodeficiency Virus Type 1 (HIV-1) Infection
go.drugbank.com/conditions/DBCOND0045921Lamivudine
go.drugbank.com/drugs/DB00709ApprovedInvestigationalA reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Categories: lamivudine, tenofovir disoproxil and doravirine